Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Lung cancer, non-small cell
Stage/Subtype:  stage I non-small cell lung cancer
Trial Type:  Treatment
Results 1-25 of 35 for your search:
Start Over
Comparison of Different Types of Surgery in Treating Patients with Stage IA Non-Small Cell Lung Cancer
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: CALGB 140503, NCI-2009-00447, CDR0000555324, ECOG-40503, NCT00499330
Erlotinib Hydrochloride in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A081105, NCI-2014-01508, CALGB A081105, NCT02193282
Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: E4512, NCI-2014-01507, NCT02201992
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: BR31, NCI-2015-01967, ACTRN12615000323527, IFCT1401, NCT02273375
Sublobar Resection or Stereotactic Ablative Radiotherapy in Treating Patients with Stage I Non-small Cell Lung Cancer
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: STU 022015-069, NCI-2015-01676, NCT02468024
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: GO29527, NCI-2015-01731, NCT02486718
Nivolumab after Surgery and Chemotherapy in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: EA5142, NCI-2015-01916, NCT02595944
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: D5164C00001, NCI-2016-00551, 2015-000662-65, NCT02511106
Indocyanine Green Solution and Near-Infrared Fluorescence Imaging in Lymph Node Mapping in Patients with Stage I-II Non-small Cell Lung Cancer Undergoing Surgery
Status: Active
Phase: Phase II, Phase I
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: 05-219, NCI-2012-00260, NCT00264602
A Phase I/II Trial of Stereotactic Body Radiation Therapy (SBRT)
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: Over 18
Trial IDs: 06-0691 / 201012832, NCI-2011-00543, 06-0691, 201012832, NCT00591838
Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: M11VOL, NCI-2015-00776, NCT01543672
Vaccine Therapy in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 11-094, NCI-2013-00081, NCT01720836
Vaccine Therapy and Iscomatrix with or without Cyclophosphamide and Celecoxib in Treating Patients with Thoracic Malignancies or Tumors That Have Spread to the Chest Cavity
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0053, NCI-2014-02465, 140053, 348360, P131392, NCT02054104
Fresolimumab and Stereotactic Ablative Radiotherapy in Treating Patients with Stage IA-IB Non-small Cell Lung Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: LUN0071, NCI-2015-01726, 4593, NCT02581787
Stereotactic Body Radiation Therapy in Treating Patients With Stage I-II Non-Small Cell Lung Cancer or Lung Metastases
Status: Temporarily closed
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: INST 0810, NCI-2011-02943, NCT00832780
Afatinib Dimaleate in Treating Patients with Stage I-III Non-small Cell Lung Cancer That Was Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-504, NCI-2013-01108, NCT01746251
Nivolumab in Treating Patients with Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 95
Trial IDs: J1414, NCI-2015-00243, CIR00010768, NA_00092076, NA_00092076/ J1414, NCT02259621
Metformin Hydrochloride in Treating Patients with Non-small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-0255, NCI-2015-00287, NCT02285855
Atezolizumab, Nab-paclitaxel, and Carboplatin before Surgery in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AAAQ3153, NCI-2016-01097, NCT02716038
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Stage IB, II, or IIIA Resectable and Untreated Non-Small Cell Lung Cancer (NSCLC)
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: ML39236, NCI-2016-01591, NCT02927301
Vaccine Therapy in Treating Patients with Non-small Cell Lung Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 08-004, NCI-2014-01874, UPCI 08-004, NCT00793208
Heated Cisplatin following Surgery in Treating Younger Patients with Primary or Metastatic Pleural Malignancies
Status: Active
Phase: Phase I
Type: Treatment
Age: 3 to 21
Trial IDs: 2012-0657, NCI-2014-01101, NCI-2014-00510, NCT01998529
Cisplatin, Docetaxel, and Nintedanib before Surgery in Treating Patients with Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2013-0844, NCI-2014-02091, NCT02225405
INO-1400 Vaccine Alone or in Combination with INO-9012 Followed by Electroporation in Treating Patients with Breast, Lung, or Pancreatic Cancer at High Risk of Relapse after Surgery and Standard Treatment
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC #22913 / Inovio TRT-00, NCI-2015-00389, 821038, UPCC 22913, NCT02327468
Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients with Stage I Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UCDCC#258, NCI-2015-01796, 774542-2, ML29955, NCT02599454
Start Over